Inspired by recent advances in frequency diverse array (FDA) and multiple–input–multiple-output (MIMO) radars, this paper investigates the target detection performance of FDA-MIMO radar, which jointly utilizes the advantages of FDA radar and MIMO radar, for single- and multiple- coherent pulses, respectively. Firstly, the signal models in target detection are formulated for FDA-MIMO, standard FDA, phased-array and MIMO radars, respectively. We present a unified framework detector to comparatively analyze their target detection performance in the Neyman-Pearson sense. Furthermore, the deflection coefficient and signal-to-interference-plus-noise ratio (SINR) are also adopted as a performance metric to compare their performance. Numerical results show that FDA-MIMO radar achieves better target detection performance as compared to other conventional radar systems, specially when multiple coherent pulses are utilized.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: